Advertisement
Advertisement
CRVS
Corvus Pharmaceuticals, Inc.
15.84
USDSponsored
-0.13
-0.81%
May 13, 16:00 UTC -4
Closed
Pre-Market
16.20
+0.36
+2.27%
CRVS Earnings Reports
Positive Surprise Ratio
CRVS beat 22 of 41 last estimates.
54%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.15
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/+50.00%
Corvus Pharmaceuticals, Inc. earnings per share and revenue
On May 07, 2026, CRVS reported earnings of -0.15 USD per share (EPS) for Q1 26, missing the estimate of -0.14 USD, resulting in a -2.95% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Corvus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Corvus Pharmaceuticals, Inc. reported EPS of -$0.15, missing estimates by -2.95%, and revenue of $0.00, 0% as expectations.
How did the market react to Corvus Pharmaceuticals, Inc.'s Q1 2026 earnings?
The stock price moved up 6.58%, changed from $14.59 before the earnings release to $15.55 the day after.
When is Corvus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Corvus Pharmaceuticals, Inc.'s next earnings report?
Based on 8
analysts, Corvus Pharmaceuticals, Inc. is expected to report EPS of -$0.15 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement